JP2022540074A5 - - Google Patents

Info

Publication number
JP2022540074A5
JP2022540074A5 JP2021578227A JP2021578227A JP2022540074A5 JP 2022540074 A5 JP2022540074 A5 JP 2022540074A5 JP 2021578227 A JP2021578227 A JP 2021578227A JP 2021578227 A JP2021578227 A JP 2021578227A JP 2022540074 A5 JP2022540074 A5 JP 2022540074A5
Authority
JP
Japan
Prior art keywords
period
pharmaceutical composition
telmisartan
treatment
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021578227A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022540074A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/030579 external-priority patent/WO2021006941A1/en
Publication of JP2022540074A publication Critical patent/JP2022540074A/ja
Publication of JP2022540074A5 publication Critical patent/JP2022540074A5/ja
Priority to JP2025068236A priority Critical patent/JP2025120167A/ja
Pending legal-status Critical Current

Links

JP2021578227A 2019-07-09 2020-04-30 イヌの慢性腎臓病の治療のためのテルミサルタン Pending JP2022540074A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025068236A JP2025120167A (ja) 2019-07-09 2025-04-17 イヌの慢性腎臓病の治療のためのテルミサルタン

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962871752P 2019-07-09 2019-07-09
US62/871,752 2019-07-09
PCT/US2020/030579 WO2021006941A1 (en) 2019-07-09 2020-04-30 Telmisartan for the treatment of chronic kidney disease in dogs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025068236A Division JP2025120167A (ja) 2019-07-09 2025-04-17 イヌの慢性腎臓病の治療のためのテルミサルタン

Publications (2)

Publication Number Publication Date
JP2022540074A JP2022540074A (ja) 2022-09-14
JP2022540074A5 true JP2022540074A5 (https=) 2023-05-11

Family

ID=70775531

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021578227A Pending JP2022540074A (ja) 2019-07-09 2020-04-30 イヌの慢性腎臓病の治療のためのテルミサルタン
JP2025068236A Pending JP2025120167A (ja) 2019-07-09 2025-04-17 イヌの慢性腎臓病の治療のためのテルミサルタン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025068236A Pending JP2025120167A (ja) 2019-07-09 2025-04-17 イヌの慢性腎臓病の治療のためのテルミサルタン

Country Status (10)

Country Link
US (1) US20220218671A1 (https=)
EP (1) EP3996705A1 (https=)
JP (2) JP2022540074A (https=)
KR (1) KR20220054291A (https=)
CN (1) CN114450004A (https=)
BR (1) BR112022000315A2 (https=)
CA (1) CA3142876A1 (https=)
MX (1) MX2022000429A (https=)
TW (1) TW202116305A (https=)
WO (1) WO2021006941A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220054292A (ko) 2019-07-09 2022-05-02 베링거잉겔하임베트메디카게엠베하 개의 고혈압 치료를 위한 텔미사르탄

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3648761T (pt) 2017-07-07 2024-06-05 Boehringer Ingelheim Vetmedica Gmbh Telmisartan para a profilaxia ou tratamento de hipertensão em gatos

Similar Documents

Publication Publication Date Title
KR100296954B1 (ko) 신규의항알러지항염증조성물
JP5241228B2 (ja) 非ステロイド性抗炎症薬、鬱血除去薬および鎮静作用の少ない抗ヒスタミン薬を含む多層錠
Al-Qattan et al. The antihypertensive effect of garlic (Allium sativum) in the rat two-kidney–one-clip Goldblatt model
JP4938905B2 (ja) 選択的s1p1レセプターアゴニストの投与法
AU2001258323A1 (en) Combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups
EP4512397A2 (en) New use of a combination of an angiotensin receptor blocker (arb) with a neutral endopeptidase inhibitor (nepi)
JP5796959B2 (ja) 関節炎における痛みの治療のためのタペンタドール
TWI539950B (zh) 用於預防或治療貓之全身性疾病之血管緊張素ii受體拮抗劑
JP2013521304A5 (https=)
DK3027183T3 (en) SELECTIVE AT2 RECEPTOR AGONISTS FOR USING CACKSY TREATMENT
JP2019529570A5 (https=)
JP2024056875A (ja) 疼痛を処置するためにフェノキシプロピルアミン化合物を使用する方法
JP2022540074A5 (https=)
JP2021514380A5 (ja) 筋障害及び骨障害を処置するための化合物及び組成物
WO2017006254A1 (en) Drug combination comprising an angiotensin ii receptor antagonist, a neutral endopeptidase inhibitor and a mineralcorticoid receptor antagonist
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
JP2022540077A5 (https=)
Vitolina et al. Aspects of the amlodipine pleiotropy in biochemistry, pharmacology and clinics
HRP20240703T1 (hr) Telmisartan za profilaksu ili liječenje hipertenzije kod mačaka
RU2022102778A (ru) Телмисартан для лечения хронической болезни почек у собак
EP4347022A1 (en) Pediatric formulations of ferric citrate
CN110325214A (zh) 用于预防和治疗神经元损伤的低剂量药物组合
Cole Pharmacology of nonsteroidal anti‐inflammatory drugs
CN116688135B (zh) 一种骨关节炎药物治疗组合物及其制备方法和应用
JP2015003902A (ja) 血管新生阻害剤